$140 Million Verdict in AndroGel Testosterone Case

A federal jury in Chicago has ordered the pharmaceutical company AbbVie Inc. to pay a Tennessee man more than $140 million as compensation for a heart attack he claimed was caused by his taking testosterone-replacement drug AndroGel.

, The National Law Journal

   | 0 Comments

A federal jury in Chicago has ordered the pharmaceutical company AbbVie Inc. to pay a Tennessee man more than $140 million as compensation for a heart attack he claimed was caused by his taking the testosterone-replacement drug AndroGel.

This premium content is reserved for Daily Business Review subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202799985134

Thank you!

This article's comments will be reviewed.